05 / Protect brain and mind
Neurodevelopmental and neurodegenerative disease along with mental health disorders represent a massive and growing unmet need with no simple solutions available.
Why it matters
Mental health disorders and neurological diseases affect more than 1 billion people. Therapies for neurodegenerative diseases like Parkinson’s disease and dementia have seen little progress in decades, with no disease-modifying therapies available today. We invest in companies building new technology toolboxes with the aspiration of reversing degenerative and developmental neurological diseases and regaining mental health.
What if: cell and gene therapies could be used to develop medicines that reverse the loss of brain cells in devastating diseases like Alzheimer’s disease, ALS, or Parkinson’s? Researchers are also beginning to untangle the human microbiome, establishing linkages between gut health, the immune system, and the brain. What if we could cure depression or anxiety by restoring microbiome health?
Category
healthCompanies addressing this leap
It’s our responsibility to engage society
We collaborate with partners worldwide to engage others in industry, academia, leaders, and civil society in this critical dialogue.